Phase 3 trial fails to show benefit of solanezumab in mild Alzheimer's disease

The Brown University Psychopharmacology Update,Volume 29, Issue 6, Page 4-5, June 2018.

Source: The Brown University Psychopharmacology Update - April 30, 2018 Category: Psychiatry Source Type: research